The Neurolutions Team
Leo Petrossian, Chief Executive Officer
Leo Petrossian is the current Chief Executive Officer of Neurolutions, Inc. He is an experienced nanotechnologist searching for challenging opportunities in biotechnology and medical device entre- and intrapreneurship. Previously he co-founded Neural Analytics and is also the CEO of Nile AI, Inc.
Dr. Petrossian earned his MBA from the UCLA Anderson School of Management in 2014 and earned his Ph.D. & MS in Biomolecular Nanotechnology & Solid-State Device Physics as an NSF IGERT fellow at Arizona State University in 2007. He also holds a double B.S. in Electrical Engineering & Biomedical Engineering from California State University, Long Beach.
Kern Bhugra, Chief Operating Officer
Kern has over 20 years of experience in executive management and technology development in the medical device space. His career began
at IBM with responsibilities ranging from medical imaging to global technology operations in the US, Europe, and Asia. Kern co-founded Tibion Corporation, a leader in neuro-rehabilitation, in 2002 and drove Tibion from concept through commercialization and acquisition after serving as CEO/Chairman for 7 yrs. Following Tibion, Kern ran JunoPacific Inc., a medical device design, development, and manufacturing firm, where he grew the company to over 350 employees through acquisitions and organic expansion over his five-year tenure. After JunoPacific, Kern became the CEO at Neurolutions, where he built the team and
led the company through technology design, research & development, clinical studies, and managing the regulatory pathway to market entry.
He is also an inventor on several Neurolutions device technology patents.
In addition to Neurolutions, Kern served on the boards of Aerin Medical, Leonis Medical, an educational non-profit institution, as well as on the medical device screening committee of a Bay Area angel group. Kern has been a speaker at numerous conferences and academic institutions in the US, Europe, and Asia as well as a guest lecturer at Oxford University, Stanford University, and UC Berkeley. He holds several patents in the area of robotics-based neuro-rehabilitation. Kern received a BSEE from the University of Michigan and an MSEE with an emphasis in bioengineering from Stanford University.
Eric Leuthardt, Co-Founder and Chief Scientific Officer
Eric C. Leuthardt, M.D. is a neurosurgeon who is currently a professor in the Departments of Neurological Surgery, Neuroscience, Biomedical Engineering, Mechanical Engineering, and Material Sciences at Washington University in St. Louis. He is also Chief of the Division of Neurotechnology. Leuthardt is an internationally renowned neurosurgeon and scientist.
His research has focused on thought-controlled devices linked to the brain that may restore function to patients with various types of disabilities.
His work in the field of neuroprosthetics, neurotechnologies, advanced brain imaging, and neurosurgical devices has yielded him numerous accolades as a pioneer in applied neuroscience. In addition to numerous peer-reviewed publications, Leuthardt has over 1800 patents on file with the U.S. Patent and Trademark Office for a myriad of medical devices and brain-computer interface technologies. He is also the founder of eight startup companies, an Emmy Award-winning playwright, and the author of two fiction novels, Red Devil 4 and Limbo.
Dan Moran, Co-Founder
Daniel Moran received his undergraduate degree in Biomedical Engineering from the Milwaukee School of Engineering and his Ph.D. degree in Bioengineering from Arizona State University. Given his interest in neural engineering, Dr. Moran performed a postdoctoral fellowship in Systems Neurophysiology at the Neurosciences Institute in San Diego. Currently, Dr. Moran is a Professor in Biomedical Engineering at Washington University with joint appointments in Neurosurgery, Neuroscience, and Physical Therapy.
Dr. Moran’s primary research interest is in the area of voluntary motor control. His lab investigates how various neural substrates control arm movements. Furthermore, Dr. Moran’s lab applies these scientific results to the development of novel neuroprosthetics devices. Current research projects involve controlling complex 3D musculoskeletal arm models with cortical signals and developing novel peripheral nerve interfaces for muscle control and haptic feedback. The goal of this research is to restore voluntary arm control in paralyzed individuals via motor cortical recordings and functional electrical stimulation of arm muscles or prosthetic limbs.
Lauren Souders, Senior Director of Clinical Affairs and Market Development
Lauren Souders is the current Director of Clinical Operations for Neurolutions, Inc., and has been working with Neurolutions since 2012 assisting in the development and clinical evolution of applying brain-computer interface in the stroke rehabilitation space. Lauren was an integral clinical lead in the infancy of Neurolutions' first product, the IpsiHand. Lauren is also one of the first pioneering occupational therapists to assist in using brain-computer interface technology with stroke patients.
Lauren has held other clinical roles as an occupational therapist with advanced certifications as a certified brain injury specialist (CBIS) and a certified stroke rehabilitation specialist (CSRS). Lauren also served as an adjunct faculty member at Saint Louis University and a clinical specialist for Washington University’s School of Medicine’s Department of Neurology. Lauren has presented at a number of conferences for the American Occupational Therapy Association and the American Congress of Rehabilitation Medicine. Lauren continues to serve as a guest lecturer at a number of universities including Saint Louis University and Maryville University. Lauren is a founding member of two other start-up companies. Overall, Lauren aspires to innovate creative medical technologies to provide solutions to improve the lives of those who need it the most.
Rob Coker, Senior Director of Engineering
Rob Coker is currently Director of Engineering for Neurolutions, Inc. Rob has been working with Neurolutions since 2012 in product design and development and was instrumental in the design of the IpsiHand from concept through its current stage. With a background in the medical, aircraft, rail, and agricultural industries, Rob has a broad perspective on development in regulated environments where safety is a critical concern.
Rob holds a Ph.D. in Biomedical Engineering from Washington University in St Louis and a Masters of Science in Electrical Engineering from the University of Missouri. He has had executive responsibility, cross-functional leadership, and extensive experience as an individual contributor to the development of innovative, technically sophisticated products.
Emily Morgan, Clinical Relations Manager
Emily J. Morgan, MS, OTRL, CSRS, CBIS, LSVT BIG, and PWR! Certified, RPSFC in NDT is an occupational therapist with 16 years of experience practicing and managing outpatient rehabilitation neurological care. Expertise includes upper extremity motor recovery and advanced technology in patient populations such as stroke, brain injury, and Parkinson’s disease.
Emily serves as the Clinical Relations Manager for Neurolutions. Emily is pleased to work collaboratively with stroke survivors and medical professionals to meet shared goals of improving function and reclaiming lives after stroke. She looks forward to providing education and on-site/remote clinical training and connecting with those wanting to learn more about the IpsiHand and solutions for promoting neurological recovery.
Kelly Carr, Clinical Manager
Kelly Carr, OTR/L, CLT-LANA, is the current clinical manager at Neurolutions. She originally joined the team in 2014 during the infancy of the Ipsihand and first clinical trial, remaining actively engaged in the team since, but is excited to join full time in 2022. Kelly brings to the team over a decade of experience as an occupational therapist in all continuums of care, specifically in the world of neuro-rehabilitation. Kelly has held multiple advanced certifications including certified brain injury specialist (CBIS), certified lymphedema therapist (CLT-LANA), certified crisis prevention specialist instructor, and certified as a rater of the ISNCSCI.
Kelly also served as an adjunct faculty member and guest lecturer at Washington University in St. Louis and Saint Louis University. Kelly's experience also includes clinical specialist and research coordinator for Washington University’s School of Medicine’s Department of Neurology in multiple research studies. Kelly has presented at a number of conferences and panels. Overall, Kelly strives to continue to improve the lives of persons with all abilities throughout rehabilitation, specifically with the use of technology and evidenced based interventions.